The U.S. health insurance market faces significant premium hikes and systemic challenges linked to legislative changes, economic burdens, and disparities. Comparing with the U.K., the analysis highlights reform difficulties and financial implications for policy makers and insurers.
Discover how the AMA's new obstetric coding will improve maternity care and patient outcomes starting in 2027. Learn about changes and implications for care providers.
A new Senate bill aims to lower prescription drug costs for Medicare beneficiaries by prioritizing affordable generics and biosimilars, providing potential savings.
Explore the $3M Medicare Advantage study examining non-medical benefits like food aid and transportation, assessing their effects on health outcomes and emergency visits.
Discussion on the Affordable Care Act's impact on healthcare consolidation and insurance market trends amidst ongoing subsidy debates and market dynamics.
Congressional hearing investigates rising U.S. healthcare costs, examining regulatory roles and the impact of medical technology innovations on affordability.
Analysis finds health care consolidation and rising costs in the U.S. health system largely predate the Affordable Care Act, with complex market and financial factors driving trends beyond ACA influence.
An overview of key issues in U.S. health insurance, FDA regulatory inconsistencies, health care costs, anti-vaccine impacts, and emerging digital health policies affecting public health.
The expiration of enhanced ACA health insurance subsidies could double premiums, reduce coverage for millions, and strain state budgets, with significant economic and healthcare impacts nationwide.
Recent legislative changes to Medicare’s drug price negotiation program expand orphan drug exclusions, delaying price negotiation for expensive specialty drugs and increasing costs for Medicare beneficiaries.
